100 related articles for article (PubMed ID: 17931598)
1. [Ca2+]i and PKC-alpha are involved in the inhibitory effects of Ib, a novel nonpeptide AngiotensinII subtype AT1 receptor antagonist, on AngiotensinII-induced vascular contraction in vitro.
Wang Y; Wang W; Wang Q; Wu J; Xu J; Wu X
Biochem Biophys Res Commun; 2007 Dec; 364(1):118-23. PubMed ID: 17931598
[TBL] [Abstract][Full Text] [Related]
2. PKC-dependent extracellular signal-regulated kinase 1/2 pathway is involved in the inhibition of Ib on AngiotensinII-induced proliferation of vascular smooth muscle cells.
Wang Y; Yan T; Wang Q; Wang W; Xu J; Wu X; Ji H
Biochem Biophys Res Commun; 2008 Oct; 375(1):151-5. PubMed ID: 18687307
[TBL] [Abstract][Full Text] [Related]
3. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
[TBL] [Abstract][Full Text] [Related]
4. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
Arun KH; Kaul CL; Ramarao P
Cardiovasc Res; 2005 Feb; 65(2):374-86. PubMed ID: 15639476
[TBL] [Abstract][Full Text] [Related]
5. Pinocembrin inhibits angiotensin II-induced vasoconstriction via suppression of the increase of [Ca2+]i and ERK1/2 activation through blocking AT(1)R in the rat aorta.
Li L; Pang XB; Chen BN; Gao L; Wang L; Wang SB; Wang SB; Liu DP; Du GH
Biochem Biophys Res Commun; 2013 May; 435(1):69-75. PubMed ID: 23611777
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
7. Methyl-beta-cyclodextrin prevents angiotensin II-induced tachyphylactic contractile responses in rat aorta.
Linder AE; Thakali KM; Thompson JM; Watts SW; Webb RC; Leite R
J Pharmacol Exp Ther; 2007 Oct; 323(1):78-84. PubMed ID: 17636007
[TBL] [Abstract][Full Text] [Related]
8. AT1 receptors and the actin cytoskeleton during angiotensin II treatment.
Bertels IM; Gontijo JA; Figueiredo JF
J Nephrol; 2007; 20(1):29-35. PubMed ID: 17347970
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II acutely decreases myocardial stiffness: a novel AT1, PKC and Na+/H+ exchanger-mediated effect.
Leite-Moreira AF; Castro-Chaves P; Pimentel-Nunes P; Lima-Carneiro A; Guerra MS; Soares JB; Ferreira-Martins J
Br J Pharmacol; 2006 Mar; 147(6):690-7. PubMed ID: 16415904
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL
Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces matrix metalloproteinase-9 expression via a nuclear factor-kappaB-dependent pathway in vascular smooth muscle cells.
Guo RW; Yang LX; Wang H; Liu B; Wang L
Regul Pept; 2008 Apr; 147(1-3):37-44. PubMed ID: 18252266
[TBL] [Abstract][Full Text] [Related]
12. Increased tail artery vascular responsiveness to angiotensin II in cold-treated rats.
Shechtman O; Sun Z; Fregly MJ; Katovich MJ
Can J Physiol Pharmacol; 1999 Dec; 77(12):974-9. PubMed ID: 10606444
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effects of angiotensin II and receptor antagonism on aggregability and protein kinase C phosphorylation in human platelets.
Utsugisawa K; Kizawa H; Nagane Y; Kondoh R; Iwa Y; Akutsu H; Tohgi H; Terayama Y
Thromb Haemost; 2005 Nov; 94(5):1012-8. PubMed ID: 16363245
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
[TBL] [Abstract][Full Text] [Related]
15. Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation.
Yang X; Wang F; Chang H; Zhang S; Yang L; Wang X; Cheng X; Zhang M; Ma XL; Liu H
J Hypertens; 2008 Aug; 26(8):1629-35. PubMed ID: 18622242
[TBL] [Abstract][Full Text] [Related]
16. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
Shen J; Yip S; Wang Z; Wang W; Xing D; Du L
Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858
[TBL] [Abstract][Full Text] [Related]
17. Intracellular actions of angiotensin II in vascular smooth muscle cells.
Haller H; Lindschau C; Quass P; Luft FC
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S75-83. PubMed ID: 9892144
[TBL] [Abstract][Full Text] [Related]
18. Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats.
Zhao X; Zhang LK; Zhang CY; Zeng XJ; Yan H; Jin HF; Tang CS; DU JB
Hypertens Res; 2008 Aug; 31(8):1619-30. PubMed ID: 18971538
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 2 receptor provides an endogenous brake during inflammation-induced microvascular fluid leak.
Ereso AQ; Ramirez RM; Sadjadi J; Cripps MW; Cureton EL; Curran B; Victorino GP
J Am Coll Surg; 2007 Oct; 205(4):527-33. PubMed ID: 17903725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
